Accessibility Menu
 
Mesoblast logo

Mesoblast

(OTC) MEOBF

Current Price$1.60
Market Cap$2.05B
Since IPO (2007)+42%
5 Year-8%
1 Year+16%
1 Month+0%

Mesoblast Financials at a Glance

Market Cap

$2.05B

Revenue (TTM)

$17.20M

Net Income (TTM)

$102.14M

EPS (TTM)

$-0.07

P/E Ratio

-21.57

Dividend

$0.00

Beta (Volatility)

-0.16 (Low)

Price

$1.60

Volume

100

Open

$1.60

Previous Close

$1.60

Daily Range

$1.60 - $1.60

52-Week Range

$0.96 - $2.59

MEOBF News

No articles available.

MEOBF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mesoblast

Industry

Biotechnology

Employees

81

CEO

Silviu Itescu, PhD

Headquarters

Melbourne, VIC 3000, AU

MEOBF Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-6%

Net Income Margin

-6%

Return on Equity

-18%

Return on Capital

-17%

Return on Assets

-13%

Earnings Yield

-4.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.05B

Shares Outstanding

1.29B

Volume

100

Short Interest

0.00%

Avg. Volume

92.57K

Financials (TTM)

Gross Profit

$12.07M

Operating Income

$62.44M

EBITDA

$73.66M

Operating Cash Flow

$49.95M

Capital Expenditure

$730.00K

Free Cash Flow

$50.68M

Cash & ST Invst.

$161.16M

Total Debt

$128.16M

Mesoblast Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$7.02M

+458.6%

Gross Profit

$16.23M

-69.4%

Gross Margin

-2.31%

N/A

Market Cap

$2.05B

N/A

Market Cap/Employee

$28.06M

N/A

Employees

73

N/A

Net Income

$27.10M

+2.2%

EBITDA

$19.64M

-28.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$5.57M

+93.7%

Accounts Receivable

$43.30M

+2465.2%

Inventory

$21.66M

-10.5%

Long Term Debt

$66.02M

-37.8%

Short Term Debt

$69.12M

+247.6%

Return on Assets

-13.06%

N/A

Return on Invested Capital

-16.81%

N/A

Free Cash Flow

$15.69M

-51.2%

Operating Cash Flow

$15.56M

-50.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SZUKFSuzuken Co., Ltd.
$30.30+0.00%
GENSFGenus plc
$35.97+0.00%
STSEYStratec SE
$5.51+0.00%
PHMMFPharma Mar, S.A.
$92.19+3.91%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About MEOBF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.